Wall street set for muted open, retail earnings mixed
Wall Street looked set to open little changed on Tuesday after three days of gains, with a mixed bag of retail earnings keeping investors guessing...
U.S. banking regulator approves simpler ‘Volcker Rule’ ban on proprietary trading
A U.S. banking regulator announced Tuesday he had approved a final rule simplifying the “Volcker Rule,” which restricts risky profit-seeking trades by banks....
Kohl’s profit beat lifts shares as partnerships pay off
Department store operator Kohl’s Corp reported better-than-expected quarterly profit on Tuesday and said it expected to benefit from new partnerships and the expansion of its...
Chinese smartphone maker Xiaomi misses estimates as competition hots up at home
China’s Xiaomi Corp reported 15% growth in quarterly revenue on Tuesday, missing estimates, as fewer people bought smartphones at home and rival Huawei grabbed market...
Qualcomm strikes new licensing deal with LG
Qualcomm Inc said on Tuesday that it has entered into a new five-year patent license agreement with LG Electronics Inc to develop, manufacture and sell...
Oil edges lower, but hopes on easing trade tensions cap losses
Oil prices edged lower on Tuesday on persisting concerns over demand, but optimism U.S.-China trade tensions will ease and hopes major economies will take stimulus...
Stocks futures subdued after strong rebound on stimulus hopes
U.S. stock index futures treaded water on Tuesday as investors paused after a three-day run that was driven by hopes that major economies would act...
U.S. yield curve: Invert, steepen, repeat
A swift steepening of the U.S. 2-year/10-year yield curve after it inverted last week may have given investors hope that the United States can escape...
Huawei founder details ‘battle mode’ reform plan to beat U.S. crisis
China’s Huawei will spend more on production equipment this year to ensure supply continuity, cut redundant roles and demote inefficient managers as its grapples with...
Elanco to buy Bayer’s animal health unit for $7.6 billion
Elanco Animal Health said on Tuesday it would buy Bayer’s veterinary drugs unit in a cash and stock deal valued at $7.6 billion, creating the...